The UK’s national innovation agency, the Technology Strategy Board, has selected a consortium, which includes Quantix as its Oracle hosting and Managed Services provider, to deliver a cloud-based Oracle platform to support medicine research and cross-organisational collaboration. The consortium is led by independent software vendor IDBS and also includes leading cancer centers at Kings Health Partners and Manchester Academic Health Science Center.
Quantix already has a close partnership with IDBS through several different projects, delivering a fully managed hosting solution which enables software as a service delivery of IDBS applications to their clients. The partnership allows a powerful combination of skills to be offered to IDBS’ broad R&D and Healthcare customer base and, as healthcare costs grow, interest in collaborative efforts to support stratified medicines as a means to deliver safe and cost-effective treatments increase.
Alongside cost benefits, the cloud-based platform provides multi-site delivery, securely integrated into other IT systems, huge capacity for data storage which offers on-demand scalability and inherent high availability with built in resiliency and backup. In addition, Quantix bring their experience of provisioning complex applications via a SaaS delivery model and extensive expertise of Oracle software with proven database and application solutions, which, coupled with IDBS’s pioneering application environments, is a unique cloud hosting offering. The platform provides the infrastructure for multiple organisations within the health science industry to support secure stratified medical research and collaboration including data handling, storage, retrieval and analysis services which will gather and integrate data from a wide variety of different organisations and sources.
This project will allow leading cancer centers across the UK to identify patient populations and develop better understanding of genetic drivers for cancer, to improve cancer care and more effective drugs and diagnostics. In addition to the benefits to patients, it provides unprecedented collaboration between organisations throughout medical research and industry, leading the UK’s research activities to the next level.
“Quantix is extremely proud to be a part of such a significant project – not only does it highlight the benefits of our cloud computing solutions, our expertise with Oracle software, and the strength of the application hosting platform we have developed, but it also demonstrates the wider advantages to UK industry and the medical research communities which our platform, and cloud-based platforms can offer.” said Simon Goodenough, Sales & Marketing Director of Quantix.